Tenzing Acquisition

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch TZAC and buy or sell other stocks, ETFs, and their options commission-free!

About TZAC

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. 

CEO
Laxminarayan Bhat, PhD
CEOLaxminarayan Bhat, PhD
Employees
14
Employees14
Headquarters
Cupertino, California
HeadquartersCupertino, California
Founded
2020
Founded2020
Employees
14
Employees14

TZAC Key Statistics

Market cap
408.97M
Market cap408.97M
Price-Earnings ratio
-0.46
Price-Earnings ratio-0.46
Dividend yield
—
Dividend yield—
Average volume
4.69M
Average volume4.69M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$4.28
52 Week high$4.28
52 Week low
$0.30
52 Week low$0.30

People also own

Based on the portfolios of people who own TZAC. This list is generated using Robinhood data, and it’s not a recommendation.
Social Capital Hedosophia
Foley Trasimene
Haymaker Acquisition
Gores Holdings
Desktop Metal
Apex Technology
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.